Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Ablynx (EBR:ABLX) Publication of transparency notifications in accordance with Article 14 of the Belgian Act of 2 May 2007 regarding the publication of major shareholdings
GHENT, Belgium, 5 November 2008 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins, announced today that it has received transparency notifications from various shareholders pursuant to the entry into force of the new Belgian transparency legislation (Belgian Act of May 2, 2007 concerning major holdings in issuers whose shares are admitted to trading on a Belgian regulated market).
Ablynx received the following notifications of holdings as per 1 September 2008.
+-------------------------------------------------------------------+ | Notifying | Number of | Percentage | Remarks | | person(s) | voting | of voting | | | | rights | rights | | |-----------------+-----------+------------+------------------------| | GIMV NV, | 6,924,764 | 19.00% | GIMV NV (3,147,960 | | Adviesbeheer | | | voting rights), | | GIMV Life | | | Adviesbeheer GIMV Life | | Sciences NV and | | | Sciences NV (555,523 | | Biotech Fonds | | | voting rights) and | | Vlaanderen | | | Biotech Fonds | | | | | Vlaanderen NV | | | | | (3,221,281 voting | | | | | rights) act in | | | | | concert. | |-----------------+-----------+------------+------------------------| | Sofinnova | 5,927,830 | 16.27% | Sofinnova Partners SAS | | Partners SAS | | | is the management | | | | | company of Sofinnova | | | | | Capital IV FCPR. | |-----------------+-----------+------------+------------------------| | Abingworth | 4,102,952 | 11.26% | Abingworth Management | | Management | | | Limited (3,817,308 | | Limited and | | | voting rights) acts as | | Abingworth LLP | | | a manager of | | | | | Abingworth Bioventures | | | | | IV LP and Abingworth | | | | | Bioventures IV | | | | | Executives LP and | | | | | exercises voting | | | | | rights for shares | | | | | owned by those funds. | | | | | Abingworth LLP | | | | | (285,644 voting | | | | | rights) acts as a | | | | | manager of Abingworth | | | | | Bioventures V LP and | | | | | Abingworth Bioequities | | | | | Fund LP and exercises | | | | | voting rights for | | | | | shares owned by those | | | | | funds. | |-----------------+-----------+------------+------------------------| | Alta California | 3,135,583 | 8.61% | | | Partners IV, LP | | | | |-----------------+-----------+------------+------------------------| | Gilde Europe | 2,941,772 | 8.07% | | | Food & | | | | | Agribusiness | | | | | Fund B.V. | | | | |-----------------+-----------+------------+------------------------| | C.H. Boehringer | 2,142,857 | 5.88% | C.H. Boehringer Sohn | | Sohn AG & Co. | | | AG & Co. KG (0 voting | | KG | | | rights) is the parent | | | | | undertaking | | | | | controlling Boehringer | | | | | Ingelheim | | | | | International GmbH | | | | | (2,142,857 voting | | | | | rights). | |-----------------+-----------+------------+------------------------| | Multifund B.V., | 1,900,000 | 5.21% | Nederlandia | | Nederlandia | | | Investments B.V. acts | | Investments | | | in its own name but | | B.V. and | | | for the account of | | Stichting | | | Stichting Avivia. | | Avivia | | | Multifund B.V. | | | | | (570,000 voting | | | | | rights), Nederlandia | | | | | Investments B.V. | | | | | (1,330,000 voting | | | | | rights) and Stichting | | | | | Avivia act in concert, | | | | | on the basis of an | | | | | agreement to hold, | | | | | acquire or dispose of | | | | | voting rights. | |-----------------+-----------+------------+------------------------| | KBC Groep NV | 1,589,286 | 4.36% | KBC Groep NV (0 voting | | and KBC Private | | | rights) is the parent | | Equity NV | | | company controlling | | | | | KBC Bank NV (0 voting | | | | | rights) and KBC Bank | | | | | NV controls KBC | | | | | Private Equity NV | | | | | (1,589,286 voting | | | | | rights). | |-----------------+-----------+------------+------------------------| | VIB VZW | 1,375,000 | 3.77% | | |-----------------+-----------+------------+------------------------| | KBC Asset | 1,246,738 | 3.42% | The shares are owned | | Management NV | | | by a number of funds | | | | | which are managed by | | | | | KBC Asset Management | | | | | NV. KBC Asset | | | | | Management NV can | | | | | exercise the voting | | | | | rights at its | | | | | discretion rights | | | | | independently from the | | | | | issuer. | +-------------------------------------------------------------------+
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
